Reuters logo
BRIEF-Geneuro FY operating revenues rise to 5.9 million euros
April 27, 2017 / 6:39 PM / 5 months ago

BRIEF-Geneuro FY operating revenues rise to 5.9 million euros

April 27 (Reuters) - Geneuro SA:

* Top-Line results from phase IIb multiple sclerosis trial expected early Q4 2017

* Cash and cash equivalents amounted to EUR 34.5 million at December 31, 2016, compared with EUR 18.6 million at December 31, 2015

* FY operating revenues EUR 5.9 million versus EUR 2.5 million year ago

* Fy net loss EUR 14.1 million versus loss of EUR 4.5 million year ago

* Release intermediate six-month results for GNBAC1 is expected early in Q4 of 2017

* Fy operating loss EUR 14.0 million versus loss of EUR 4.3 million year ago

* Plans to launch a clinical trial in progressive forms of MS by year-end 2017

* Plans to launch a clinical trial in progressive forms of MS in the us for GNBAC1 by year-end 2017

* Expects results of Australian phase II study in GNBAC1 clinical development expansion to type I diabetes in Q3 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom:)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below